S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
NASDAQ:CHNA

Loncar China BioPharma ETF Stock Forecast, Price & News

$35.34
-0.12 (-0.34 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$35.34
$35.34
50-Day Range
$35.05
$41.98
52-Week Range
$29.25
$49.01
Volume464 shs
Average Volume4,684 shs
Market Capitalization$14.14 million
P/E RatioN/A
Dividend Yield0.44%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CHNA News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China BioPharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Exchange Traded Concepts
Fund NameLoncar China Biopharma ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:CHNA
Inception Date8/14/2018
Fund ManagerDenise M. Krisko, Habib Moudachirou
WebN/A

Fund Focus

Asset ClassEquity
BenchmarkLoncar China BioPharma Index
CategorySector
FocusHealth Care
Development LevelEmerging Markets
RegionAsia-Pacific

Fund Statistics

Assets Under Management$11.75 million
Average Daily Volume$4,075.70
Discount/Premium-0.02%

ETF Expenses

Management Fee0.79%
Other Expenses0.00%
Total Expenses0.79%
Fee Waiver0.00%
Net Expenses0.79%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorExchange Traded Concepts, LLC
CustodianU.S. Bank, N.A.
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker

Geographic Exposure of CHNA

Currency Exposure of CHNA

Sector Exposure of CHNA

Industry Exposure of CHNA













Loncar China BioPharma ETF (NASDAQ:CHNA) Frequently Asked Questions

What stocks does MarketBeat like better than Loncar China BioPharma ETF?

Wall Street analysts have given Loncar China BioPharma ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Loncar China BioPharma ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Loncar China BioPharma ETF?

Loncar China BioPharma ETF saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 1,100 shares, a decline of 21.4% from the August 31st total of 1,400 shares. Based on an average trading volume of 4,500 shares, the days-to-cover ratio is presently 0.2 days.
View Loncar China BioPharma ETF's Short Interest
.

How has Loncar China BioPharma ETF's stock price been impacted by Coronavirus?

Loncar China BioPharma ETF's stock was trading at $24.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CHNA shares have increased by 45.4% and is now trading at $35.3401.
View which stocks have been most impacted by COVID-19
.

How often does Loncar China BioPharma ETF pay dividends? What is the dividend yield for Loncar China BioPharma ETF?

Loncar China BioPharma ETF declared an annual dividend on Tuesday, December 29th. Investors of record on Thursday, December 31st will be given a dividend of $0.155 per share on Monday, January 4th. This represents a yield of 0.48%. The ex-dividend date is Wednesday, December 30th.
View Loncar China BioPharma ETF's dividend history
.

Is Loncar China BioPharma ETF a good dividend stock?

Loncar China BioPharma ETF pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.44%.
View Loncar China BioPharma ETF's dividend history.

Who are some of Loncar China BioPharma ETF's key competitors?

What other stocks do shareholders of Loncar China BioPharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China BioPharma ETF investors own include Baidu (BIDU), salesforce.com (CRM), (CGC), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), (APHA), Advanced Micro Devices (AMD) and Analog Devices (ADI).

What is Loncar China BioPharma ETF's stock symbol?

Loncar China BioPharma ETF trades on the NASDAQ under the ticker symbol "CHNA."

How do I buy shares of Loncar China BioPharma ETF?

Shares of CHNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Loncar China BioPharma ETF's stock price today?

One share of CHNA stock can currently be purchased for approximately $35.34.

How much money does Loncar China BioPharma ETF make?

Loncar China BioPharma ETF has a market capitalization of $14.14 million.

How many employees does Loncar China BioPharma ETF have?

Loncar China BioPharma ETF employs 147,000 workers across the globe.

How can I contact Loncar China BioPharma ETF?

The company can be reached via phone at 14089961010.


This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.